Cryo-Cell International, Inc. (CCEL) Financials
CCEL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| May 31, 2026 | 60.7 million | 78.5 million |
| Feb. 28, 2026 | 60.9 million | 79.3 million |
| Nov. 30, 2025 | 61.7 million | 80.3 million |
| Aug. 31, 2025 | 63.2 million | 78.0 million |
CCEL Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| May 31, 2026 | 1.8 million | -158549 |
| Feb. 28, 2026 | 584762 | 158549 |
| Nov. 30, 2025 | 1.2 million | 42903 |
| Aug. 31, 2025 | 2.5 million | 36780 |
CCEL Net Income
No data available :(
CCEL Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| May 31, 2026 | 3.2 million | 8.1 million | 260664 |
| Feb. 28, 2026 | 2.9 million | 368941 | 795195 |
| Nov. 30, 2025 | 3.3 million | 8.2 million | 904849 |
| Aug. 31, 2025 | 3.2 million | 577202 | - |
CCEL Shares Outstanding
CCEL Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| May 31, 2026 | 32701 | 99781 | 4.6 million | - |
| Feb. 28, 2026 | 67065 | 65761 | 5.0 million | - |
| Nov. 30, 2025 | 67226 | 84784 | 5.4 million | - |
| Aug. 31, 2025 | 38788 | 61625 | 3.9 million | - |
CCEL Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| May 31, 2026 | 7.8 million | 1.9 million |
| Feb. 28, 2026 | 7.7 million | 1.7 million |
| Nov. 30, 2025 | 7.8 million | 1.7 million |
| Aug. 31, 2025 | 7.8 million | 1.8 million |
CCEL Revenue by Segment
CCEL
Price: $3.47
Forward Dividend Yield: 16.35%
Dividend Per Share: 0.60 USD
Earnings Per Share: -0.31 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 6000
Market Capitalization: 27.9 million
Average Dividend Frequency: 4
Years Paying Dividends: 2